article thumbnail

Westlake Village BioPartners Raises $500M In Two Funds

socalTECH

Los Angeles-based life sciences investor Westlake Village BioPartners announced today that it has raised two new venture capital funds, worth a total of $500M, for its investments in biotech companies. The venture investor says it has now raised more than $820M in total for its investments. READ MORE>>.

article thumbnail

Westlake Village BioPartners Taps Former SVB Leerink Exec As COO

socalTECH

Los Angeles-based venture capital investor Westlake Village BioPartners said on Wednesday that it has named Peter Calveley, previously Managing Director in the Investment Banking Group at SVB Leerink, as its Chief Operating Officer. Calveley previously also served at Merrill Lynch and Alexion Pharmaceuticals.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Westlake Village BioPartners, Led By Amgen Vets, Launches $320M Fund

socalTECH

Westlake Village BioPartners , a brand new venture capital fund focused on the life sciences, said on Wednesday that it has launched a new, $320 investment fund aimed at early stage companies. According to the new venture fund, it was founded by Beth Seidenberg, M.D., executive vice president and head of R&D at Amgen.

article thumbnail

ACELYRIN Snags Funding For Biotech Effort

socalTECH

Los Angeles-based ACELYRIN , a new startup biopharma company, announced this morning that it has raised a Series A funding. The funding came from Westlake Village BioPartners. Beth Seidenberg, MD, co-founding managing director of Westlake Village BioPartners, has joined ACELYRIN's board as part of the funding.

article thumbnail

Westlake Bio Unveils $320M Fund to Put Los Angeles on the Biotech Map

Xconomy

Los Angeles has long been in San Francisco’s shadow when it comes to life sciences investment. But a new venture capital firm led by industry veterans is trying to cast the City of Angels in a new light. Westlake Village BioPartners is launching today with $350 million in committed capital.

article thumbnail

Report: IPOs On Track For Best Year Since 2007, But Only One Q3 Area Tech IPO

socalTECH

However, local numbers show only one technology related IPO in the local market-- Sienna Biopharmaceuticals in Westlake Village. The only local IPOs identified in Q3 in the report were YogaWorks in Culver City, RBB Bancorp in Los Angeles, and Sienna Biopharmaceuticals in Westlake Village. READ MORE>>.

article thumbnail

Causal IQ Expands Into Las Vegas

socalTECH

Los Angeles-based programmatic advertising provider Causal IQ said last week that it is expanding into Las Vegas, as part of an expansion to serve the casino-entertainment market. and Westlake Village, California. and Westlake Village, California. Causal IQ is led by CEO Farshad Fardad. READ MORE>>.